About The Medical Condition Drug Evaluation, FDA Phase II
Find the definition of the medical term Drug Evaluation, FDA Phase II. Drug Evaluation, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase II
| Drug Evaluation, FDA Phase II Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase II?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Vitamin D-Resistant Rickets ‐ Familial disorder characterized by hypophosphatemia associated…
- Skin Diseases, Parasitic ‐ Skin diseases caused by arthropods, helminths, or…
- Outtakes (PT) ‐ Untitled raw motion picture and video footage which has not been…
- Oxidative Phosphorylations ‐ Electron transfer through the cytochrome system liberating free…
- Iodotyrosine ‐ A product from the iodination of tyrosine. In the biosynthesis…
- Beta-1 Subunit, Integrin ‐ Integrin beta-1 chains which are expresssed as heterodimers noncovalently…
- Cell Lineages ‐ The developmental history of cells as traced from the first division…
- Leukemias, Acute Myelocytic ‐ Progressive, malignant disease of the myeloid tissue in which…
- Antiaggregants, Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
- Rev-Responsive Elements, HIV ‐ DNA sequences that form the coding region for the viral envelope…